Top Ten Reports
 |
TreatmentTrends®: US Nephrology (Wave 4)
TreatmentTrends®, September 2011 |
 |
Special Report: Opportunities in Ophthalmology
Special Report, October 2011 |
 |
LaunchTrends®: Melanoma (Yervoy & Zelboraf) US
LaunchTrends®, November 2011 |
 |
TreatmentTrends®: US Multiple Sclerosis (Wave 2)
TreatmentTrends®, June 2011 |
 |
ChartTrends®: Renal Anemia in China
ChartTrends®, July 2011 |
 |
TreatmentTrends®: Kidney Transplant (EU)
TreatmentTrends®, August 2011 |
 |
LaunchTrends®: Incivek & Victrelis (Wave 1)
LaunchTrends®, July 2011 |
 |
TreatmentTrends®: Gout (US)
TreatmentTrends®, June 2011 |
 |
Special Report: Impact of the Dialysis Bundled Payment System (Wave 1)
Special Report, June 2011 |
 |
ChartTrends®: Rheumatoid Arthritis (US)
ChartTrends®, November 2011
|
BioTrends in Brief
Sign up to receive monthly updates on our products and services!
Decision Resources Group companies include: